One of the leading private clinical pathology laboratories in Ethiopia, International Clinical Laboratories (ICL and Cerba Lancet Africa signed an agreement to upgrade the clinical pathology services in Ethiopia to enable healthcare providers to deliver essential medical support to patients throughout the country.
ICL, which has served more than 3 million patients over the past 17 years, will make use of Cerba HealthCare's top-notch knowledge range and its already-established pan-African network to satisfy the diagnostic tool expectations of patients, doctors, and hospitals across Ethiopia.
“Joining the Cerba HealthCare family is one of my greatest achievements in terms of being able to expand our service and continue to provide quality tests to the population of Ethiopia and the surrounding region. It will allow us to tap into the huge resources and expertise of Cerba HealthCare, specifically in field of oncology, genetics, companion diagnostics, preventive medicine, patient and physician education and research to tackle unique and challenging issues," said ICL Ethiopia Chief Executive Director, Dr Tamrat Bekele.
Managers of Cerba Lancet says the partnership not only will allow ICL to bolster its unique position in Ethiopia but also serve thousands of patients from surrounding region including Somalia, Djibouti and South Sudan.
"I am pleased to count on the Cerba Lancet Africa 1,600 employees’ team spirit and professionalism to welcome the talented people of ICL Ethiopia.” Cerba Lancet Africa CEO Stéphane Carré commented.